The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer

OBJECTIVE: To determine the efficacy, progression-free survival (PFS) and overall survival (OS) for the combination of intravenous bevacizumab and oral cyclophosphamide in heavily pretreated patients with recurrent ovarian carcinoma. METHODS: A retrospective review was performed for all patients wit...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Barber, Emma L., Zsiros, Emese, Lurain, John R., Rademaker, Alfred, Schink, Julian C., Neubauer, Nikki L.
Médium: Artigo
Jazyk:Inglês
Vydáno: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2013
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3714464/
https://ncbi.nlm.nih.gov/pubmed/23875076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2013.24.3.258
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky